Literature DB >> 9256500

Carboxyfullerenes as neuroprotective agents.

L L Dugan1, D M Turetsky, C Du, D Lobner, M Wheeler, C R Almli, C K Shen, T Y Luh, D W Choi, T S Lin.   

Abstract

Two regioisomers with C3 or D3 symmetry of water-soluble carboxylic acid C60 derivatives, containing three malonic acid groups per molecule, were synthesized and found to be equipotent free radical scavengers in solution as assessed by EPR analysis. Both compounds also inhibited the excitotoxic death of cultured cortical neurons induced by exposure to N-methyl-D-aspartate (NMDA), alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), or oxygen-glucose deprivation, but the C3 regioisomer was more effective than the D3 regioisomer, possibly reflecting its polar nature and attendant greater ability to enter lipid membranes. At 100 microM, the C3 derivative fully blocked even rapidly triggered, NMDA receptor-mediated toxicity, a form of toxicity with limited sensitivity to all other classes of free radical scavengers we have tested. The C3 derivative also reduced apoptotic neuronal death induced by either serum deprivation or exposure to Abeta1-42 protein. Furthermore, continuous infusion of the C3 derivative in a transgenic mouse carrying the human mutant (G93A) superoxide dismutase gene responsible for a form of familial amyotrophic lateral sclerosis, delayed both death and functional deterioration. These data suggest that polar carboxylic acid C60 derivatives may have attractive therapeutic properties in several acute or chronic neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9256500      PMCID: PMC23208          DOI: 10.1073/pnas.94.17.9434

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain.

Authors:  J Garthwaite; S L Charles; R Chess-Williams
Journal:  Nature       Date:  1988-11-24       Impact factor: 49.962

Review 2.  Glutamate and the pathophysiology of hypoxic--ischemic brain damage.

Authors:  S M Rothman; J W Olney
Journal:  Ann Neurol       Date:  1986-02       Impact factor: 10.422

3.  An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria.

Authors:  P C Wong; C A Pardo; D R Borchelt; M K Lee; N G Copeland; N A Jenkins; S S Sisodia; D W Cleveland; D L Price
Journal:  Neuron       Date:  1995-06       Impact factor: 17.173

4.  BDNF or IGF-I potentiates free radical-mediated injury in cortical cell cultures.

Authors:  B J Gwag; J Y Koh; M M Chen; L L Dugan; M M Behrens; D Lobner; D W Choi
Journal:  Neuroreport       Date:  1995-12-29       Impact factor: 1.837

5.  Glutamate receptor-induced 45Ca2+ accumulation in cortical cell culture correlates with subsequent neuronal degeneration.

Authors:  D M Hartley; M C Kurth; L Bjerkness; J H Weiss; D W Choi
Journal:  J Neurosci       Date:  1993-05       Impact factor: 6.167

Review 6.  Ischemia-induced neuronal apoptosis.

Authors:  D W Choi
Journal:  Curr Opin Neurobiol       Date:  1996-10       Impact factor: 6.627

7.  Neuroprotective effects of phenyl-t-butyl-nitrone in gerbil global brain ischemia and in cultured rat cerebellar neurons.

Authors:  T L Yue; J L Gu; P G Lysko; H Y Cheng; F C Barone; G Feuerstein
Journal:  Brain Res       Date:  1992-03-06       Impact factor: 3.252

8.  Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain.

Authors:  J P MacManus; A M Buchan; I E Hill; I Rasquinha; E Preston
Journal:  Neurosci Lett       Date:  1993-12-24       Impact factor: 3.046

9.  Attenuation of glutamate-induced neuronal swelling and toxicity in transgenic mice overexpressing human CuZn-superoxide dismutase.

Authors:  P H Chan; L Chu; S F Chen; E J Carlson; C J Epstein
Journal:  Acta Neurochir Suppl (Wien)       Date:  1990

10.  Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis.

Authors:  M E Ripps; G W Huntley; P R Hof; J H Morrison; J W Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

View more
  91 in total

1.  Molecular dynamics analysis of a buckyball-antibody complex.

Authors:  William H Noon; Yifei Kong; Jianpeng Ma
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

2.  Epoxyeicosatrienoic acids are involved in the C(70) fullerene derivative-induced control of allergic asthma.

Authors:  Sarah K Norton; Dayanjan S Wijesinghe; Anthony Dellinger; Jamie Sturgill; Zhiguo Zhou; Suzanne Barbour; Charles Chalfant; Daniel H Conrad; Christopher L Kepley
Journal:  J Allergy Clin Immunol       Date:  2012-06-02       Impact factor: 10.793

3.  Inhibition of group A streptococcus infection by carboxyfullerene.

Authors:  N Tsao; T Y Luh; C K Chou; J J Wu; Y S Lin; H Y Lei
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

4.  In vivo studies of fullerene-based materials using endohedral metallofullerene radiotracers.

Authors:  D W Cagle; S J Kennel; S Mirzadeh; J M Alford; L J Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

5.  Distinct Impacts of Fullerene on Cognitive Functions of Dementia vs. Non-dementia Mice.

Authors:  Yawen Wu; Runzi Wang; Yuexiang Wang; Jing Gao; Lina Feng; Zhuo Yang
Journal:  Neurotox Res       Date:  2019-06-20       Impact factor: 3.911

Review 6.  Novel nanomaterials for clinical neuroscience.

Authors:  Jamie L Gilmore; Xiang Yi; Lingdong Quan; Alexander V Kabanov
Journal:  J Neuroimmune Pharmacol       Date:  2008-01-22       Impact factor: 4.147

7.  Effect of fullerenes C60 on the activity of pyramidal neurons in the CA1 field of rat hippocampal slices.

Authors:  O L Kordonets; O V Godukhin; I Y a Podolski; L M Chailakhyan
Journal:  Dokl Biol Sci       Date:  2008 Nov-Dec

8.  Modulation of tumor necrosis factor-mediated cell death by fullerenes.

Authors:  Ljubica Harhaji; Aleksandra Isakovic; Ljubica Vucicevic; Kristina Janjetovic; Maja Misirkic; Zoran Markovic; Biljana Todorovic-Markovic; Nadezda Nikolic; Sanja Vranjes-Djuric; Zoran Nikolic; Vladimir Trajkovic
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

9.  Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics.

Authors:  B X Chen; S R Wilson; M Das; D J Coughlin; B F Erlanger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

Review 10.  Amyotrophic lateral sclerosis: progress and prospects for treatment.

Authors:  Michel Dib
Journal:  Drugs       Date:  2003       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.